154
Views
0
CrossRef citations to date
0
Altmetric
Oncology

SEPTIN3 Promotes Progression of Triple-Negative Breast Cancer via Activating Wnt Pathway

ORCID Icon, & ORCID Icon
Pages 4155-4164 | Received 22 May 2023, Accepted 05 Sep 2023, Published online: 12 Sep 2023

References

  • Gradishar WJ, Moran MS, Abraham J, et al. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(6):691–722. doi:10.6004/jnccn.2022.0030
  • Wang C, Xu K, Wang R, Han X, Tang J, Guan X. Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer. J Exp Clin Cancer Res. 2021;40(1):370. doi:10.1186/s13046-021-02164-6
  • Altundag K. Pembrolizumab in triple-negative breast cancer. N Engl J Med. 2022;387(15):1435–1436. doi:10.1056/NEJMc2210919
  • Li Y, Zhang H, Merkher Y, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121. doi:10.1186/s13045-022-01341-0
  • Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular alterations in triple-negative breast cancer-The road to new treatment strategies. Lancet. 2017;389(10087):2430–2442. doi:10.1016/S0140-6736(16)32454-0
  • Schneider BP, Winer EP, Foulkes WD, et al. Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res. 2008;14(24):8010–8018. doi:10.1158/1078-0432.CCR-08-1208
  • Zhou L, Rueda M, Alkhateeb A. Classification of breast cancer Nottingham prognostic index using high-dimensional embedding and residual neural network. Cancers. 2022;14(4). doi:10.3390/cancers14040934
  • Parsons MJ, Tammela T, Dow LE. WNT as a driver and dependency in cancer. Cancer Discov. 2021;11(10):2413–2429. doi:10.1158/2159-8290.CD-21-0190
  • Galluzzi L, Spranger S, Fuchs E, Lopez-Soto A. WNT signaling in cancer immunosurveillance. Trends Cell Biol. 2019;29(1):44–65. doi:10.1016/j.tcb.2018.08.005
  • Xu X, Zhang M, Xu F, Jiang S. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Mol Cancer. 2020;19(1):165. doi:10.1186/s12943-020-01276-5
  • Freeman J, Smith D, Latinkic B, et al. A functional connectome: regulation of Wnt/TCF-dependent transcription by pairs of pathway activators. Mol Cancer. 2015;14:206. doi:10.1186/s12943-015-0475-1
  • Liu X, Klein PS. Glycogen synthase kinase-3 and alternative splicing. Wiley Interdiscip Rev RNA. 2018;9(6):e1501. doi:10.1002/wrna.1501
  • Bernemann C, Hulsewig C, Ruckert C, et al. Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling. Mol Cancer. 2014;13:174. doi:10.1186/1476-4598-13-174
  • Rodgers SJ, Ooms LM, Oorschot VMJ, et al. INPP4B promotes PI3Kalpha-dependent late endosome formation and Wnt/beta-catenin signaling in breast cancer. Nat Commun. 2021;12(1):3140. doi:10.1038/s41467-021-23241-6
  • Rosa HVD, Leonardo DA, Brognara G, et al. Molecular recognition at septin interfaces: the switches hold the key. J Mol Biol. 2020;432(21):5784–5801. doi:10.1016/j.jmb.2020.09.001
  • Fujishima K, Kiyonari H, Kurisu J, Hirano T, Kengaku M. Targeted disruption of Sept3, a heteromeric assembly partner of Sept5 and Sept7 in axons, has no effect on developing CNS neurons. J Neurochem. 2007;102(1):77–92. doi:10.1111/j.1471-4159.2007.04478.x
  • Xue J, Tsang CW, Gai WP, et al. Septin 3 (G-septin) is a developmentally regulated phosphoprotein enriched in presynaptic nerve terminals. J Neurochem. 2004;91(3):579–590. doi:10.1111/j.1471-4159.2004.02755.x
  • Toth V, Vadaszi H, Ravasz L, et al. Neuronal-specific septin-3 binds Atg8/LC3B, accumulates and localizes to autophagosomes during induced autophagy. Cell Mol Life Sci. 2022;79(9):471. doi:10.1007/s00018-022-04488-8
  • Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417–425. doi:10.1016/j.cels.2015.12.004
  • Wu SY, Wang H, Shao ZM, Jiang YZ. Triple-negative breast cancer: new treatment strategies in the era of precision medicine. Sci China Life Sci. 2021;64(3):372–388. doi:10.1007/s11427-020-1714-8
  • Calvo F, Ranftl R, Hooper S, et al. Cdc42EP3/BORG2 and septin network enables mechano-transduction and the emergence of cancer-associated fibroblasts. Cell Rep. 2015;13(12):2699–2714. doi:10.1016/j.celrep.2015.11.052
  • Montagna C, Lyu MS, Hunter K, et al. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res. 2003;63(9):2179–2187.
  • Targa B, Klipfel L, Cantaloube I, et al. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel. Cell Death Dis. 2019;10(2):54. doi:10.1038/s41419-019-1318-6
  • Kamatari YO, Ohta S, Inoshima Y, et al. Identification and characterization of a multispecific monoclonal antibody G2 against chicken prion protein. Protein Sci. 2014;23(8):1050–1059. doi:10.1002/pro.2491
  • Zhang G, Feng W, Wu J. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-beta-induced epithelial-mesenchymal transition (EMT). Biomed Pharmacother. 2020;125:109768. doi:10.1016/j.biopha.2019.109768
  • Yu J, Zhang W, Tang H, et al. Septin 2 accelerates the progression of biliary tract cancer and is negatively regulated by mir-140-5p. Gene. 2016;589(1):20–26. doi:10.1016/j.gene.2016.05.005
  • Koch S, Acebron SP, Herbst J, Hatiboglu G, Niehrs C. Post-transcriptional Wnt signaling governs epididymal sperm maturation. Cell. 2015;163(5):1225–1236. doi:10.1016/j.cell.2015.10.029
  • Marquardt J, Chen X, Bi E. Septin assembly and remodeling at the cell division site during the cell cycle. Front Cell Dev Biol. 2021;9:793920. doi:10.3389/fcell.2021.793920